Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Hôpital Lariboisiere, AP-HP, Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Vrije Universiteit Brussel (VUB), University of Rouen - Rouen University Hospital, Technische Universität München (TUM) - Klinikum Rechts der Isar, University of Gothenburg - Institute of Neuroscience and Physiology, University of Gothenburg - Institute of Neuroscience and Physiology, University of Perugia - Department of Medicine, University of Göttingen - Department of Neurology, University of Göttingen - Department of Neurology, University of Montpellier, Carlos III Institute of Health, Carlos III Institute of Health, Carlos III Institute of Health, Hôpital Lariboisiere, AP-HP, University of Antwerp - Department of Biomedical Sciences, University of Antwerp - Department of Biomedical Sciences, University of Perugia - Department of Medicine, University of Perugia - Department of Medicine, Technische Universität München (TUM), Technische Universität München (TUM), Hôpital Lariboisiere, AP-HP, Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, University of Rouen - Rouen University Hospital, Hôpital Lariboisière, University of Montpellier, Hôpital Lariboisière, Lariboisiere Hospital, AP-HP, Independent, University of Bordeaux - Bordeaux Population Health Research Center, Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Hôpital Lariboisiere, AP-HP and Université Paris I Panthéon-Sorbonne - Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases